Treating kids with malaria at home doesn't work

April 14, 2009 By MARIA CHENG , AP Medical Writer

(AP) -- Treating African children at home for malaria doesn't help in cities because most fevers aren't actually caused by malaria, a new study said Tuesday.

Malaria drugs were distributed to households where parents had been told by researchers to automatically treat their if they became feverish.

Roughly half the children were treated at home while the other half were taken to health clinics within a day of developing a fever.

To effectively treat malaria, children must be treated within a day of getting sick. The study found that children at home got twice as many medicines as those taken to clinics, but didn't do any better.

The research highlights holes in malaria treatment across the continent and raises questions about an upcoming U.N. initiative to fight the disease.

Experts monitored more than 400 children aged between 1 and 6 in Kampala, Uganda, from 2005-2007.

The research was published online Tuesday in the medical journal, Lancet. It was paid for by the Gates Malaria Partnership.

Malaria, which is spread by mosquito bites and carries symptoms such as fever, chills and vomiting, primarily affects poor people in remote areas.

Some doctors said the study showed a worrying tendency to treat fevers before they were diagnosed as malaria.

"If you just go on fever, you're over-treating so many children and you could miss other diseases by using malaria drugs," said Dr. Tido von-Schoen Angerer of Medecins Sans Frontieres, aka Doctors Without Borders. He was not linked to the study.

Malaria medicines don't work on fevers caused by other diseases like , and children can die if they are not properly treated.

Previous studies have found home treatment works in . But malaria is also a problem in cities, and will have to be tackled differently there than in the countryside.

Von-Schoen Angerer said the Lancet study underlined that standard care for malaria in Africa is appalling.

Despite decades of work and renewed U.N. efforts to combat the disease, only 5 percent of children in Uganda are promptly treated with effective medication. Across Africa, the World Health Organization puts the figure at 3 percent.

WHO estimates malaria sickens about 247 million people and kills nearly 1 million every year.

Later this week, the United Nations and partners will announce a $200 million strategy called the Affordable Medicines Facility for Malaria to make drugs cheaper in 11 African countries.

Von-Schoen Angerer and others worry the tendency to over-treat malaria, as proven by the study, will be worsened by the strategy. They fear it will flood the market with drugs that promote resistance.

The initiative, led by WHO and the Global Fund to fight AIDS, tuberculosis and malaria, will subsidize the price of artemesinin combination therapies, the most effective malaria treatments.

But the U.N. has not insisted the drugs be combined in a single pill, which would curb the resistance risk.

Artemesinin combination therapies are also sold as several pills. Some cause side effects like nausea, and patients commonly throw those pills out, encouraging resistance.

"The risk of resistance is very scary," von-Schoen Angerer said. "We don't have a back-up medicine at this stage."

Richard Tren, director of the nonprofit Africa Fighting , called the U.N. initiative "an untested experiment," and warned the strategy could backfire.

"We need policies based on evidence," he said. "And the evidence this could work is pretty shaky."


On the Net:

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Stories

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.